2021-01-04,b'ADC Therapeutics prendra part au SternIR Virtual Corporate Access Event $ADCT https://t.co/662KKozQt5'
2021-01-04,b'ADC Therapeutics nimmt am SternIR Virtual Corporate Access Event teil $ADCT https://t.co/8icGq7Y7Tv'
2021-01-04,b'$ADCT ADC Therapeutics to Participate in SternIR Virtual Corporate Access Event https://t.co/Kx7VIXB6Vy'
2021-01-04,b'$ADCT ADC Therapeutics to Participate in SternIR Virtual Corporate Access Event https://t.co/QGHJR51bwS'
2021-01-04,b'$ADCT - ADC Therapeutics to Participate in SternIR Virtual Corporate Access Event https://t.co/1C4UDiN12z https://t.co/aEoAX02eSG'
2021-01-04,b'New Form 6-K  entry filed by  $ADCT #ADCTherapeutics SA  https://t.co/XgOG9R317g'
2021-01-04,b'$ADCT\nADC Therapeutics to Participate in SternIR Virtual Corporate Access Event'
2021-01-04,b'ADC Therapeutics to Participate in SternIR Virtual Corporate Access Event $ADCT https://t.co/aBxLu2NgQa'
2021-01-04,b'$ADCT ADC Therapeutics to Participate in SternIR Virtual Corporate Access Event\nhttps://t.co/qHnWWOoHnr'
2021-01-04,b'50% Above Price target\n$ACH\n$ACMR\n$ACOR\n$ACTG\n$ADCT\n$ADT\n$AIH\n$AKUS\n$ALPN\n$AMEH\n$AMPY\n$AMRK\n$AOUT\n$APRN\n$ARLP\n$ARQT\n$ASC\n$ASLE\n$ASRV\n$ATEX\n$ATNI\n$ATRA\n$ATRS\n$ATXI\n$AWRE\n$AXAS\n$BCEI\n$BCRX\n$BCYC\n$BDTX\n$BFRA\n$CABA\n$CDXC\n$CELP\n$CEPU\n$CGEN\n$CHA\n$CHL\n$CHRS\n$CHU\n$CLDX\n$CLVS\n$CLXT\n$CNQ'
2021-01-03,"b'RT @Jimbobnilsson: \xe2\x9e\xa1\xef\xb8\x8f#AVCT has partnerships with LG Chem, ADC Therapeutics $ADCT and Daewoong. \n\xe2\x9e\xa1\xef\xb8\x8f2019 Moderna $MRNA exercised option to en\xe2\x80\xa6'"
2021-01-03,"b'RT @Jimbobnilsson: \xe2\x9e\xa1\xef\xb8\x8f#AVCT has partnerships with LG Chem, ADC Therapeutics $ADCT and Daewoong. \n\xe2\x9e\xa1\xef\xb8\x8f2019 Moderna $MRNA exercised option to en\xe2\x80\xa6'"
2021-01-03,"b'RT @Jimbobnilsson: \xe2\x9e\xa1\xef\xb8\x8f#AVCT has partnerships with LG Chem, ADC Therapeutics $ADCT and Daewoong. \n\xe2\x9e\xa1\xef\xb8\x8f2019 Moderna $MRNA exercised option to en\xe2\x80\xa6'"
2021-01-03,"b'\xe2\x9e\xa1\xef\xb8\x8f#AVCT has partnerships with LG Chem, ADC Therapeutics $ADCT and Daewoong. \n\xe2\x9e\xa1\xef\xb8\x8f2019 Moderna $MRNA exercised option to enter into an exclusive licensing agreement with respect to certain Affimers against a potential therapeutic target\n4/X'"
2021-01-01,b'@Biotech2k1 @PaulieVal @CathieDWood @ARKInvest @BioStocks @Biotech2050 @Biotech_SD Sexy high science is cool but lets not forget good ole proven surgical targeted therapy platforms like $SGEN $ZYME $ADCT - i continue to remain ADC therapies to benefit from genomic revolution and AI-enabled drug design!'
2021-01-01,"b'RT @adctherapeutics: We are pleased to announce that the Biologics License Application for our lead investigational product, an anti-CD19,\xe2\x80\xa6'"
2021-01-01,"b'RT @adctherapeutics: We are pleased to announce that the Biologics License Application for our lead investigational product, an anti-CD19,\xe2\x80\xa6'"
2021-01-01,"b'RT @adctherapeutics: We are pleased to announce that the Biologics License Application for our lead investigational product, an anti-CD19,\xe2\x80\xa6'"
2020-12-30,b'Rose Above 50 DMA today: $PDFS $FOSL $MKL $ELAN $SWN $CHCT $ADCT $MGEN $FTV $GCP $WKHS $NXTC $IFF $PBA $PSA $JNUG $MCHI $FR $WWR $DTIL ... https://t.co/qwiJH6vr1O'
2020-12-30,b'RT @adctherapeutics: #ICYMI: An archived version of our #ASH20 conference call and webcast with Dr. Mehdi Hamadani @MediHumdani is availabl\xe2\x80\xa6'
2020-12-30,b'RT @adctherapeutics: #ICYMI: An archived version of our #ASH20 conference call and webcast with Dr. Mehdi Hamadani @MediHumdani is availabl\xe2\x80\xa6'
2020-12-30,b'RT @adctherapeutics: #ICYMI: An archived version of our #ASH20 conference call and webcast with Dr. Mehdi Hamadani @MediHumdani is availabl\xe2\x80\xa6'
2020-12-29,b'50 DMA Support today: $SOLN $ADCT ... https://t.co/aW7zteKP9U'
2020-12-29,"b'RT @adctherapeutics: We are pleased to announce that the Biologics License Application for our lead investigational product, an anti-CD19,\xe2\x80\xa6'"
2020-12-29,"b'RT @adctherapeutics: We are pleased to announce that the Biologics License Application for our lead investigational product, an anti-CD19,\xe2\x80\xa6'"
2020-12-29,b'RT @adctherapeutics: #ICYMI: An archived version of our #ASH20 conference call and webcast with Dr. Mehdi Hamadani @MediHumdani is availabl\xe2\x80\xa6'
2020-12-28,b'$MKKGY $BCYC $ADCT $PFE $BNTX $QURE $AZN $BVXV $ACIU $RHHBY $CMPS $GILD $GLPG $IMTX $REGN $CVAC $ABBV $GMAB $GNFT $ITOS $IDRSF $NVS $SLN $DNPUF  A Year to Remember: The Biggest European Biotech News in 2020 https://t.co/i9LaATRtI5 via Labiotech_eu'
2020-12-27,b'RT @stageanalysis: $ADCT Breaking out above the Supply Line with a higher low. 50 day MA starting to turn up. So signs of Stage 1 base form\xe2\x80\xa6'
2021-01-08,"b'ADC Therapeutics will participate in the SternIR Virtual Corporate Access Event. Our presentation will be available for on-demand viewing beginning January 11, 2021, at 7 a.m. ET. $ADCT https://t.co/ss0Jq6teAM https://t.co/4cYC6AXcL3'"
2021-01-08,b'$ADCT Call Block https://t.co/aMuch71dRp'
2021-01-08,"b'RT @adctherapeutics: ADC Therapeutics, together with Overland Pharmaceuticals, has formed Overland ADCT BioPharma to develop and commercial\xe2\x80\xa6'"
2021-01-08,"b'$ADCT HC Wainwright Maintains Buy Rating On ADC Therapeutics, $47 PT https://t.co/cb3L9M2Wa9'"
2021-01-08,b'Where is money flowing today?  #MoneyFlow #StockMarket $DDD $NEWR $BEAM $ACIA $FUTU $WDFC $NNOX $PLUG $EXPI $BIDU $TRIP $X $KYMR $AI $TWOU $MTLS $TWST $NIO $BE $CIG $VYCT $BILI $KC $GT $PENN $U $NBIX $DNLI $TSLA $SWI $BB $SDC $CERT $W $KOD $ADCT $PD $MDL\n\nhttps://t.co/XI8lv3aiDg https://t.co/8JGffEyDSo'
2021-01-08,"b'RT @adctherapeutics: ADC Therapeutics, together with Overland Pharmaceuticals, has formed Overland ADCT BioPharma to develop and commercial\xe2\x80\xa6'"
2021-01-08,"b'RT @adctherapeutics: ADC Therapeutics, together with Overland Pharmaceuticals, has formed Overland ADCT BioPharma to develop and commercial\xe2\x80\xa6'"
2021-01-08,"b""Rose Above Previous Day's High today: $ADCT $EGHT $SNOW $BRO $AJAX $CEQP $EZA $CDAY $FUV $CZZ $APPN $MMP $NTNX $HIGA $GEL $ECH $SRLN $FUSN $PE $TUFN ... https://t.co/TBYRpvrFqi"""
2021-01-08,b'#ADCTherapeutics Initiates Expanded Access Program for #LoncastuximabTesirine in the U.S. $ADCT https://t.co/i0uoOTTbvZ'
2021-01-08,b'$ADCT ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S. https://t.co/Az3mUEjlG9'
2021-01-07,b'RT @adctherapeutics: #ICYMI: An archived version of our #ASH20 conference call and webcast with Dr. Mehdi Hamadani @MediHumdani is availabl\xe2\x80\xa6'
2021-01-07,"b'$ADCT [15s. delayed]: Issued Press Release on January 07, 14:34:00: ADC Therapeutics startet Expanded-Access-Programm f\xc3\xbcr Loncastuximab-Tesirin in den USA https://t.co/MACoTTQwSF'"
2021-01-07,b'$ADCT $GRAY https://t.co/7Z6TzsxZqq'
2021-01-07,b'ADC Therapeutics initiates expanded access program for loncastuximab tesirine in the U.S. $ADCT https://t.co/JGMEm0gvpn'
2021-01-07,b'$ADCT NEW ARTICLE : ADC Therapeutics initiates expanded access program for loncastuximab tesirine in the U.S. https://t.co/iZNLl5IhqP Get all the latest $ADCT related news here : https://t.co/As306fMhTr'
2021-01-07,b'$ADCT - ADC Therapeutics initiates expanded access program for loncastuximab tesirine in the U.S. https://t.co/ETPnLmgnsz'
2021-01-07,"b'$ADCT -the initiation of an expanded access program (EAP) for loncastuximab tesirine (Lonca, formerly ADCT-402) for patients in the US with relapsed or refractory diffuse large B-cell lymphoma.'"
2021-01-07,b'$ADCT ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S. | Business Wire https://t.co/frvcicOq83'
2021-01-07,b'$ADCT ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S. https://t.co/hMgq3KgIuI'
2021-01-07,b'New Form 6-K  entry filed by  $ADCT #ADCTherapeutics SA  https://t.co/YXLUKs1Maw'
2021-01-07,b'$ADCT NEW ARTICLE : ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S. https://t.co/iIdnOyqhui Get all the latest $ADCT related news here : https://t.co/As306fMhTr https://t.co/03cLqUVahp'
2021-01-07,b'ADC Therapeutics announces EAP for loncastuximab tesirine for certain patients\n$ADCT'
2021-01-07,"b'$ADCT [15s. delayed]: Issued Press Release on January 07, 07:15:00: ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S. https://t.co/B6I3YoVcYv'"
2021-01-07,b'$ADCT\nADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S.'
2021-01-07,b'ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S. $ADCT https://t.co/PRgkixHSz1'
2021-01-07,b'$ADCT ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S.\nhttps://t.co/2XAMy85m9r'
